Targeting 14-3-3 adaptor protein-protein interactions to stimulate central nervous system repair.

Neural Regen Res

Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, Québec, Canada.

Published: July 2017

AI Article Synopsis

Article Abstract

The goal of developing treatments for central nervous system (CNS) injuries is becoming more attainable with the recent identification of various drugs that can repair damaged axons. These discoveries have stemmed from screening efforts, large expression datasets and an improved understanding of the cellular and molecular biology underlying axon growth. It will be important to continue searching for new compounds that can induce axon repair. Here we describe how a family of adaptor proteins called 14-3-3s can be targeted using small molecule drugs to enhance axon outgrowth and regeneration. 14-3-3s bind to many functionally diverse client proteins to regulate their functions. We highlight the recent discovery of the axon-growth promoting activity of fusicoccin-A, a fungus-derived small molecule that stabilizes 14-3-3 interactions with their client proteins. Here we discuss how fusicoccin-A could serve as a starting point for the development of drugs to induce CNS repair.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558476PMC
http://dx.doi.org/10.4103/1673-5374.211176DOI Listing

Publication Analysis

Top Keywords

central nervous
8
nervous system
8
small molecule
8
client proteins
8
targeting 14-3-3
4
14-3-3 adaptor
4
adaptor protein-protein
4
protein-protein interactions
4
interactions stimulate
4
stimulate central
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!